Skip to main content
News Icon

News categories: Honors & Funding

Honorary doctorate to Professor Jacques Miller

The University of Bonn Faculty of Medicine has awarded an honorary doctorate to renowned Australia-based immunologist Prof. Dr. Jacques Francis Albert Pierre Miller. The award ceremony was conducted online due to the corona pandemic, held as part of the Digital Cluster Science Days 2020 organized by the Cluster of Excellence ImmunoSensation2.

The ceremony took place via simultaneous videoconferencing between the lecture hall of Biomedical Center I on the Venusberg Campus and Melbourne, Australia, where Professor Miller (89) is Professor Emeritus at the Walter and Eliza Hall Institute of Medical Research. One of Miller’s former doctoral students, Professor Robyn Slattery, presented the diploma following the ceremonial pronouncement of awarding of the honorary doctorate by Professor Bernd Weber as Dean representing the University of Bonn. Speeches in honor of the recipient were made by Leibniz Prize winner Professor Christian Kurts and by Professor Sammy Bedoui, Bonn University Ambassador in Melbourne, Australia.

The board of the ImmunoSensation2 Cluster of Excellence had suggested to confer the honorary degree in recognition of Professor Miller’s outstanding achievement in the field of immunology. Jaques Miller earned wide scientific attention in the 1960s for proving that the thymus is a critically important component of the immune system as the organ where T cells are formed. The existence of T cells, as well as their key role in immunological memory against bacteria, viruses and cancer had not been appreciated prior to this discovery.

Congratulations Jaques Miller for this honorary degree and the Cluster ImmunoSensation is happy to have such close ties with its partners the University of Melbourne in operating The Bonn and Melbourne Research and Graduate School (Bo&MeRanG) for the Immunosciences.


Media contact

Prof. Dr. Christian Kurts

Phone: +49 (0) 228 287-11050

Email: ckurts@uni-bonn.de

Related news

Gut

News categories: Honors & Funding

Millions in funding for the new MikrobiomProCheck research project

The human gut microbiome is as unique as a fingerprint. It plays a central role in chronic inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Yet its potential for diagnostics and personalized therapy for patients remains untapped. The MikrobiomProCheck research project aims to change this. To this end, the Leibniz Institute for Analytical Sciences (ISAS), the Universities of Bonn, Bielefeld, and Duisburg-Essen, Biofidus AG, and Lead Discovery Center GmbH are receiving approximately 3.4 million euros from the state government of NRW and the European Union.
View entry
Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

News categories: Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry
PrepAIred

News categories: Honors & Funding

Precise active ingredients against pancreatic cancer

Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry

Back to the news overview